| Dr Joseph Edward Sherrill Ii, MD | |
|
1215 Pleasant St, Ste 608, Des Moines, IA 50309 | |
| (515) 875-9560 | |
| (515) 875-9561 |
| Full Name | Dr Joseph Edward Sherrill Ii |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 33 Years |
| Location | 1215 Pleasant St, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407823131 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD-36393 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unitypoint Health - Des Moines Iowa Methodist Medi | Des moines, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Iowa Clinic Pc | 4082513742 | 273 |
News Archive
Researchers from the Computational Intelligence Group based at the Universidad Politécnica de Madrid's Facultad de Informática have used machine learning and data mining techniques to compare gene expresssion levels in Alzheimer's disease (AD) patients in two key regions of the hippocampus: the dentate gyrus, where the disease appears to have little or no effect, and the entorhinal cortex, where Alzheimer's disease produces major neuronal damage.
Mylan Inc. (Nasdaq: MYL) today announced that the U.S. Food and Drug Administration (FDA) has released its official and final report regarding the agency's review of allegations made in a July newspaper article concerning the company's Morgantown, W.Va., manufacturing facility.
The notion that training teachers in the rigors of hands-on science will directly improve their students' academic performance now has real data behind it: Research assembled over the last decade - now published in the Oct. 16 issue of Science - shows that high school students' pass rate on New York State standardized tests, called Regents examinations, can be significantly improved if they are among the lucky few to study under a teacher trained in Columbia University's Summer Research Program for Science Teachers.
When it comes to cholesterol-lowering drugs, more is better. At least, that's what heart doctors and heart patients have been hearing in recent years.
OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells, announced today that it has been awarded $1.2 million to support five distinct therapeutic programs under the U.S. Government's Qualifying Therapeutic Discovery Project program.
› Verified 3 days ago
| Entity Name | The Iowa Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346233178 PECOS PAC ID: 4082513742 Enrollment ID: O20040102000222 |
News Archive
Researchers from the Computational Intelligence Group based at the Universidad Politécnica de Madrid's Facultad de Informática have used machine learning and data mining techniques to compare gene expresssion levels in Alzheimer's disease (AD) patients in two key regions of the hippocampus: the dentate gyrus, where the disease appears to have little or no effect, and the entorhinal cortex, where Alzheimer's disease produces major neuronal damage.
Mylan Inc. (Nasdaq: MYL) today announced that the U.S. Food and Drug Administration (FDA) has released its official and final report regarding the agency's review of allegations made in a July newspaper article concerning the company's Morgantown, W.Va., manufacturing facility.
The notion that training teachers in the rigors of hands-on science will directly improve their students' academic performance now has real data behind it: Research assembled over the last decade - now published in the Oct. 16 issue of Science - shows that high school students' pass rate on New York State standardized tests, called Regents examinations, can be significantly improved if they are among the lucky few to study under a teacher trained in Columbia University's Summer Research Program for Science Teachers.
When it comes to cholesterol-lowering drugs, more is better. At least, that's what heart doctors and heart patients have been hearing in recent years.
OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells, announced today that it has been awarded $1.2 million to support five distinct therapeutic programs under the U.S. Government's Qualifying Therapeutic Discovery Project program.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Edward Sherrill Ii, MD Po Box 424, Des Moines, IA 50302-0424 Ph: (515) 875-9255 | Dr Joseph Edward Sherrill Ii, MD 1215 Pleasant St, Ste 608, Des Moines, IA 50309 Ph: (515) 875-9560 |
News Archive
Researchers from the Computational Intelligence Group based at the Universidad Politécnica de Madrid's Facultad de Informática have used machine learning and data mining techniques to compare gene expresssion levels in Alzheimer's disease (AD) patients in two key regions of the hippocampus: the dentate gyrus, where the disease appears to have little or no effect, and the entorhinal cortex, where Alzheimer's disease produces major neuronal damage.
Mylan Inc. (Nasdaq: MYL) today announced that the U.S. Food and Drug Administration (FDA) has released its official and final report regarding the agency's review of allegations made in a July newspaper article concerning the company's Morgantown, W.Va., manufacturing facility.
The notion that training teachers in the rigors of hands-on science will directly improve their students' academic performance now has real data behind it: Research assembled over the last decade - now published in the Oct. 16 issue of Science - shows that high school students' pass rate on New York State standardized tests, called Regents examinations, can be significantly improved if they are among the lucky few to study under a teacher trained in Columbia University's Summer Research Program for Science Teachers.
When it comes to cholesterol-lowering drugs, more is better. At least, that's what heart doctors and heart patients have been hearing in recent years.
OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells, announced today that it has been awarded $1.2 million to support five distinct therapeutic programs under the U.S. Government's Qualifying Therapeutic Discovery Project program.
› Verified 3 days ago
Dr. David J Boarini, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-875-9560 Fax: 515-875-9561 | |
Zoya A. Voronovich, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave Ste B1, Des Moines, IA 50314 Phone: 515-358-0100 Fax: 515-358-0109 | |
Dr. Thomas A Carlstrom, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1215 Pleasant St, Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 Fax: 515-241-8161 | |
Dr. Timothy C Ryken, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 Fax: 515-241-8161 | |
Nicholas M Wetjen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 | |
Dr. Royce W Woodroffe, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-875-9560 Fax: 515-875-9561 |